Marijuana Law Reform in 2020 and Beyond: Where We Are and Where We’Re Going
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
The Green Regulatory Arbitrage
Table of Contents I. EXECUTIVE SUMMARY ...................................................................................................... 1 II. PROHIBITION - HOW CANNABIS BECAME ILLEGAL ..................................................... 4 III. THE LEGAL LANDSCAPE .................................................................................................... 7 A. Federal Law And Its Impact On The Cannabis Industry ..................................................... 7 1. Cannabis Is A Schedule 1 Substance ............................................................................ 7 2. Access To Capital Markets Restricted ......................................................................... 9 3. Banking Services Limited .......................................................................................... 10 4. Tax Burdens .............................................................................................................. 11 5. Interstate And International Commerce Restrictions ................................................. 11 6. Insurance Options Limited ........................................................................................ 12 7. Medical Research And Clinical Trials Stymied .......................................................... 12 8. Professional Services Harder To Find ........................................................................ 13 9. Real Estate Challenges .............................................................................................. 13 B. The States -
Unconstitutional Qualification of the Right to Bear Arms by the Federal Government Against Law-Abiding Medical Marijuana Patients
A STICKY SITUATION: THE UNCONSTITUTIONAL QUALIFICATION OF THE RIGHT TO BEAR ARMS BY THE FEDERAL GOVERNMENT AGAINST LAW-ABIDING MEDICAL MARIJUANA PATIENTS LUKE C. WATERS* INTRODUCTION ......................................................................................... 116 I. MEDICAL MARIJUANA LAWS ................................................................ 120 A. Comprehensive Medical Marijuana Programs ....................... 121 B. Federal Laws & Policies ........................................................ 129 1. The Ogden Memo ............................................................. 134 2. The Cole Memo ................................................................ 135 3. The Cole Recreational Memo ........................................... 137 4. The Sessions Enforcement Memo .................................... 137 5. The Rohrabacher-Farr Amendment .................................. 138 II. SECOND AMENDMENT RIGHTS ............................................................ 142 A. An Awkward Landmark Decision ......................................... 143 B. The Post-Heller Two-Step Qualification Analysis ................ 144 1. Individuals Adjudicated as Mentally-Ill ........................... 149 2. Users of Illegal Drugs ....................................................... 151 IV. UNCONSTITUTIONAL APPLICATION ................................................... 152 A. Modest Collateral Burdens: Wilson v. Lynch ......................... 153 B. Applying the Two-Step Test to Qualified Patients Appropriately -
Rethinking Federal Marijuana Policy by Ed Chung, Maritza Perez, and Lea Hunter May 1, 2018
Rethinking Federal Marijuana Policy By Ed Chung, Maritza Perez, and Lea Hunter May 1, 2018 For decades, the failed war on drugs has devastated communities across the United States, contributing to unprecedented rates of incarceration. The United States has nearly 25 percent of the world’s incarcerated population despite comprising less than 5 percent of the world’s total population.1 This phenomenon gained momentum in the 1970s when President Richard Nixon first declared a war on drugs and policy- makers at all levels of government added harsh criminal penalties for drug offenses, leading to explosive incarceration rates. Since then, the nation’s incarcerated popula- tion has increased sevenfold—from 300,000 people to 2.2 million people today—and 1 out of 5 people incarcerated are serving time for a drug offense.2 People of color have disproportionately felt the damaging and unnecessary consequences of these outdated tough-on-crime policies. Members of these communities have been sentenced to long terms of imprisonment as well as lifetimes of poverty and economic insecurity.3 According to the Drug Policy Alliance, drug enforcement in the United States is rooted in racial discrimination, as the first anti-drug laws were established around the turn of the 20th century and targeted Chinese immigrants, black Americans, and Mexican migrants.4 Today, between 40 percent and 50 percent of all drug arrests are for mari- juana.5 Discriminatory enforcement of marijuana laws is one reason that black and Latino Americans make up two-thirds of the U.S. prison population despite only comprising 12 percent and 17 percent of the U.S. -
Adapting a Regulatory Framework for the Emerging Cannabis Industry
OCTOBER 2019 Learn more about NCIA’s Policy Council TheCannabisIndustry.org/PolicyCouncil National Cannabis Industry Association TheCannabisIndustry.org ADAPTING A REGULATORY FRAMEWORK FOR THE EMERGING CANNABIS INDUSTRY National Cannabis Industry Association (NCIA) Adapting a Proven Regulatory Framework for the Emerging Cannabis Industry Table of Contents 1 EXECUTIVE SUMMARY 8 INTRODUCTION 11 LEGAL STATE OF CANNABIS IN THE UNITED STATES 13 CURRENT LEGISLATIVE EFFORTS 14 CANNABIS PRODUCTS 15 REMOVING THE OUTDATED REGULATORY STRUCTURE 16 ESTABLISHING A NEW REGULATORY FRAMEWORK 19 SOCIAL EQUITY 20 LANE #1: Pharmaceutical Drugs 23 LANE #2: Ingested, Inhaled, or Topically Applied THC Products 31 LANE #3: Ingested and Inhaled Cannabinoid Products with Low/No THC 40 LANE #4: Topically Applied Low THC Products 43 CONCLUSION National Cannabis Industry Association (NCIA) Adapting a Proven Regulatory Framework for the Emerging Cannabis Industry Executive Summary For almost a century, the United States government has criminalized the production, distribution, and sale of cannabis. However, this era of prohibition has been crumbling in the face of voter and, increasingly, legislative revolt. Even as these federal laws remain unchanged, most states have legalized some form of medical cannabis, and eleven states and the District of Columbia have changed their laws to regulate adult-use cannabis in a manner similar to alcohol. Moreover, Congress recently removed hemp (and any cannabinoids derived therefrom) from the Controlled Substances Act (CSA), legalizing -
Marijuana Legalization Has Gained Traction in Recent Years in the United
How One 11-Page Bill Could Yield Billions in Annual Benefits: The Marijuana Justice Act of 2017 Haley Dunn arijuana legalization has gained traction in recent years in the United States with a variety of bipartisan supporters. Primary benefits often cited include savings in enforcement and incarceration costs, additional tax revenue and jobs, release and expungement for those incarcerated, Mand lowered racial and economic disproportionality in the U.S. criminal justice system. Critics often bring up health costs, increases in impaired driving, harmful effects on adolescent brain development, and greater attendant crime as possible drawbacks. This article examines the potential costs and benefits of federal marijuana legalization under the Senate version of the Marijuana Justice Act of 2017 (S. 1689) introduced in the 115th Congress, assuming 30 additional states legalize recreational marijuana and set up a regulated commercial retail system. Using an analysis that operates under a net present value over 1,000 years and reflects 2017 dollar amounts, the results are overwhelming: these combined efforts could lead to nationwide lifetime net benefits of over $168 billion, with approximately $50 billion in the first year alone, and $17 billion in tax revenue that federal and state governments could receive annually. This article also runs best- and worst-case scenario sensitivity analyses in a post- enactment universe—best being one in which all 50 states legalize recreational marijuana and worst being one in which no additional states legalize. Even the worst- case scenario would lead to lifetime net benefits of over $77 billion ($4 billion/year) and, in the best case, over $1.4 trillion ($75 billion/year). -
Emerging Issues with Marijuana Legalization
Emerging Issues With Marijuana Legalization Faye Caldwell Email: [email protected] Disclaimer: no Legal advice or attorney-client relationship This presentation has been prepared by Caldwell Everson, PLLC for informational purposes only. The information presented does not constitute legal advice and is not to be acted on as such. This information is not intended to create, and receipt of it does not establish an attorney-client relationship. By participating in this presentation you are not and do not become a client of Caldwell Everson PLLC. Any information contained herein is not intended as a substitute for legal counsel. You should not rely upon any information contained in this presentation without seeking legal advice from an attorney of your choice and who practices law in your state. © Caldwell Everson PLLC 2 As of November 29, 2018: 33 states + D.C. + 2 U.S. territories (Guam, PR) have passed Comprehensive “Medical marijuana” Laws Laws vary widely 13 other states have passed low THC/High CBD laws All passed since 2014 in mostly southern states after CNN documentary Some states with comprehensive medical marijuana laws also have CBD laws 10 states + D.C. + 1 U.S. territory (CNMI) have passed recreational marijuana laws All except US territory also had comprehensive medical marijuana laws 4 states prohibit marijuana for all purposes © Caldwell Everson PLLC (Idaho, Kansas, Nebraska, South Dakota) 3 State Medical Marijuana Laws 33 states + D.C. Alaska (1998) Maine (1999) New York (2014) Arizona (2010) Maryland (2014) North Dakota (2016) Arkansas (2016) Massachusetts (2012) Ohio (2016) California (1996) Michigan (2008) Oklahoma (2018) Colorado (2000) Minnesota (2014) Oregon (1998) Connecticut (2012) Missouri (2018) Pennsylvania (2016) Delaware (2011) Montana (2004) Rhode Island (2006) Florida (2016) Nevada (2000) Utah (2018) Hawaii (2000) New Hampshire (2013) Vermont (2004) Illinois (2013) New Jersey (2010) Washington (1998) Louisiana (2015) New Mexico (2007) West Virginia (2017) Washington, D.C. -
Update: Federal Legislation Related to Cannabis
Update on Federal Legislation Related to Cannabis House Commerce & Gaming Committee March 26, 2021 Presented by Peter Clodfelter, Counsel, House Office of Program Research 1 1. Marijuana Opportunity Reinvestment and Expungement Act of 2020 (“MORE Act of 2020”) 2. Strengthening the Tenth Amendment Through Entrusting States Act (“STATES Act”) (2019) Scope of 3. Regulate Marijuana Like Alcohol Act (2019) Presentation 4. Marijuana 1-to-3 Act of 2021 5. Secure And Fair Enforcement Banking Act of 2019 (“SAFE Banking Act of 2019”) 6. Cannabidiol and Marijuana Research Expansion Act (2019, 2021) 2 Background: The Five Schedules Under the Federal CSA • Schedule I: No currently accepted medical use and a high potential for abuse ➢ Marihuana (cannabis), heroin, LSD, ecstasy, and peyote • Schedule II: High potential for abuse, with use potentially leading to severe psychological or physical dependence ➢ Vicodin, cocaine, methamphetamine, oxycodone (OxyContin), fentanyl, and Adderall • Schedule III: Moderate to low potential for physical and psychological dependence ➢ Tylenol with codeine, ketamine, anabolic steroids, and testosterone • Schedule IV: Low potential for abuse and low risk of dependence ➢ Xanax, Soma, Darvon, Darvocet, Valium, Ativan, Talwin, Ambien, Tramadol • Schedule V: Lower potential for abuse than Schedule IV and consist of preparations containing limited quantities of certain narcotics ➢ Robitussin AC, Lomotil, Motofen, Lyrica, Parepectolin 3 1. Introduced in House and Senate: ➢H.R. 3884 (Rep. Nadler-NY) (2019) ➢S. 2227 (Sen. Harris-CA) (2019) Marijuana 2. “AN ACT To decriminalize and deschedule Opportunity cannabis, to provide for reinvestment in Reinvestment certain persons adversely impacted by the War on Drugs, to provide for expungement and of certain cannabis offenses, and for other Expungement purposes” Act of 2020 3. -
State Cannabis Laws: a Progress Report Successes, Challenges, and the Need for Congressional Action
STATE CANNABIS LAWS: A PROGRESS REPORT SUCCESSES, CHALLENGES, AND THE NEED FOR CONGRESSIONAL ACTION INDUS ABIS TR N Y N AS A S C O L C A I N A T O I I O T N A N THECANNABISINDUSTRY.ORG T h g e r C .o an try nabisIndus TABLE OF CONTENTS Executive Summary ...................................................................................................................... 3 Economic Benefit - Jobs and Tax Revenue ..............................................................................7 Access to Banking Services .......................................................................................................10 Fairness in Taxation ....................................................................................................................12 Impact on Crime ..........................................................................................................................14 Reduction in Arrests but Disparities Remain ..........................................................................15 Reducing Access to Minors .......................................................................................................16 Cannabis as Part of a Comprehensive Response to the Opioid Crisis .............................19 Highway Safety ...........................................................................................................................22 Public Opinion .............................................................................................................................24 Recommendations ......................................................................................................................28 -
Marijuana Legalization Status
5/12/18 “LEGAL MARIJUANA” Can Lawyers Be Part of a Budding Industry? ©2017 First American Financial Corporation and/or its affiliates. All rights reserved. NYSE: FAF Marijuana Legalization Status ©2017 First American Financial Corporation and/or its affiliates. All rights reserved. NYSE: FAF 2018 Joint Seminar May 17-19, 2018 CH. 2 Page 1 5/12/18 Cannabis CannaBis has now Been legalized for medicinal use in 29 states and the District of ColumBia. It is also legal for recreational use in eight of these states and the District of ColumBia. ©2017 First American Financial Corporation and/or its affiliates. All rights reserved. NYSE: FAF CONTROLLED SUBSTANCES ACT ©2017 First American Financial Corporation and/or its affiliates. All rights reserved. NYSE: FAF 2018 Joint Seminar May 17-19, 2018 CH. 2 Page 2 5/12/18 Controlled Substances Act The Controlled Substances Act is Title II of the Comprehensive Drug Abuse Prevention and Control Act of 1970 (21 USC section 801 et seq). • Consolidated laws regarding manufacture, and distribution of narcotics, stimulants, depressants, hallucinogens, anabolic steroids and chemicals used in the illicit production of controlled substances. ©2017 First American Financial Corporation and/or its affiliates. All rights reserved. NYSE: FAF Controlled Substances Act • Restricted access to controlled substances. • Identification and Classification of Controlled Substances. – CSA places all regulated substances into one of five schedules based on: • Substances medical value • Harmfulness • Potential for abuse and addiction – Schedule V least dangerous-Schedule I most dangerous. ©2017 First American Financial Corporation and/or its affiliates. All rights reserved. NYSE: FAF 2018 Joint Seminar May 17-19, 2018 CH. -
"Hash"Ing out Inequality in the Legal Recreational Cannabis Industry Maya Rahwanji
Northwestern Journal of International Law & Business Volume 39 Issue 3 Spring Spring 2019 "Hash"ing Out Inequality in the Legal Recreational Cannabis Industry Maya Rahwanji Follow this and additional works at: https://scholarlycommons.law.northwestern.edu/njilb Part of the Comparative and Foreign Law Commons, Criminal Law Commons, Food and Drug Law Commons, and the Health Law and Policy Commons Recommended Citation Maya Rahwanji, "Hash"ing Out Inequality in the Legal Recreational Cannabis Industry, 39 Nw. J. Int'l L. & Bus. 333 (2019). https://scholarlycommons.law.northwestern.edu/njilb/vol39/iss3/4 This Note is brought to you for free and open access by Northwestern Pritzker School of Law Scholarly Commons. It has been accepted for inclusion in Northwestern Journal of International Law & Business by an authorized editor of Northwestern Pritzker School of Law Scholarly Commons. Copyright 2019 by Maya Rahwanji Vol. 39, No. 3 Northwestern Journal of International Law & Business “Hash”ing Out Inequality in the Legal Recreational Cannabis Industry Maya Rahwanji* TABLE OF CONTENTS I. Introduction ........................................................................................... 334 II. Background and Growth of the Legal Recreational Marijuana Industry .......................................................................................... 337 A. Legal Status of Marijuana in the United States ...................... 337 B. Profitability of the Legal Recreational Marijuana Industry .... 339 III. Statutory Requirements to Start a Legal -
Marijuana Law and Policy
Marijuana Law and Policy BermanKreit_5pp.indb 1 7/1/20 12:58 PM BermanKreit_5pp.indb 2 7/1/20 12:58 PM Marijuana Law and Policy Douglas A. Berman Newton D. Baker-Baker & Hostetler Chair in Law The Ohio State University Moritz College of Law Alex Kreit assistant Professor of Law Northern Kentucky University Chase College of Law Carolina Academic Press Durham, North Carolina BermanKreit_5pp.indb 3 7/1/20 12:58 PM Copyright © 2020 Carolina Academic Press, LLC All Rights Reserved ISBN 978-1-5310-1037-9 e-ISBN 978-1-5310-1038-6 LCCN 2020936878 Carolina Academic Press 700 Kent Street Durham, NC 27701 Telephone (919) 489-7486 Fax (919) 493-5668 www . caplaw . com Printed in the United States of Amer i ca BermanKreit_5pp.indb 4 7/1/20 12:58 PM For my entire family, all of whom have shared wisdom in various ways about various aspects of law, policy and practice in this arena. — Douglas A. Berman For my father, Leonard Kreit, whose interest in the subject matter may not have always been, strictly speaking, legal. — Alex Kreit v BermanKreit_5pp.indb 5 7/1/20 12:58 PM BermanKreit_5pp.indb 6 7/1/20 12:58 PM Contents Table of Cases xix Acknowledgments xxiii Introduction xxv Chapter 1 • What Is Marijuana, How Is It Used, and What Is It Similar To? 3 A. What Is Marijuana? 3 Marihuana, A Signal of Misunderstanding, U.S. National Commission on Marihuana and Drug Abuse (1972) 3 Marijuana — A Short History, John Hudak, Brookings Institute (2016) 5 The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research, National Academies of Sciences, Engineering, and Medicine (2017) 11 Colorado Constitution, Article XVIII, Section 16 14 Notes 15 Arizona v. -
The Evolving Federal Response to State Marijuana
Vanderbilt University Law School Scholarship@Vanderbilt Law Vanderbilt Law School Faculty Publications Faculty Scholarship Spring 4-2020 The Evolving Federal Response to State Marijuana Robert Mikos Vanderbilt University Law School Follow this and additional works at: https://scholarship.law.vanderbilt.edu/faculty-publications Part of the Food and Drug Law Commons, and the Health Law and Policy Commons Recommended Citation Robert Mikos, The Evolving Federal Response to State Marijuana, 26 Widener Law Review. 1 (2020) Available at: https://scholarship.law.vanderbilt.edu/faculty-publications/1153 This Article is brought to you for free and open access by the Faculty Scholarship at Scholarship@Vanderbilt Law. It has been accepted for inclusion in Vanderbilt Law School Faculty Publications by an authorized administrator of Scholarship@Vanderbilt Law. For more information, please contact [email protected]. DATE DOWNLOADED: Mon Jun 22 10:09:40 2020 SOURCE: Content Downloaded from HeinOnline Citations: Bluebook 20th ed. Robert A. Mikos, The Evolving Federal Response to State Marijuana Reforms, 26 Widener L. Rev. 1 (2020). ALWD 6th ed. Robert A. Mikos, The Evolving Federal Response to State Marijuana Reforms, 26 Widener L. Rev. 1 (2020). APA 7th ed. Mikos, R. A. (2020). The evolving federal response to state marijuana reforms. Widener Law Review, 26(1), 1-20. Chicago 7th ed. Robert A. Mikos, "The Evolving Federal Response to State Marijuana Reforms," Widener Law Review 26, no. 1 (2020): 1-20 McGill Guide 9th ed. Robert A Mikos, "The Evolving Federal Response to State Marijuana Reforms" (2020) 26:1 Widener L Symp J 1. MLA 8th ed.